Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis

BACKGROUND: Some people with multiple sclerosis (pwMS) are at increased risk of severe Coronavirus disease 19 (COVID-19) and should be rapidly vaccinated. However, vaccine supplies are limited, and there are concerns about side-effects, particularly with the ChAdOx1nCoV-19 (AstraZeneca) vaccine. OBJ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler Relat Disord
Main Authors: Allen-Philbey, K., Stennett, A., Begum, T., Johnson, AC., Dobson, R., Giovannoni, G., Gnanapavan, S., Marta, M., Smets, I., Turner, B.P., Baker, D., Mathews, J., Schmierer, K.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129799/
https://ncbi.nlm.nih.gov/pubmed/34049216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.103028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados